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Abstract
Background: Listeria monocytogenes is a gram-positive bacteria generally transmitted to humans through ingestion of
contaminated food. It typically infects high risk subjects, such as pregnant women, neonates, the elderly and
immunocompromised patients. Listeria meningitis is rarely reported in previously healthy children with no immunological
disorders. However, it can be aggressive in such subjects and is associated with a high mortality rate. Prompt diagnosis is
essential so that adequate antibiotic treatment can be started and the best outcome achieved.
Case presentation: We report the case of a previously healthy 16-month-old child with Listeria meningitis who was
successfully treated with intravenous ampicillin and gentamicin without any sequelae.
Conclusions: Although Listeria meningitis is rare in previously healthy immunocompetent children, it must be considered,
especially in children who do not improve with first-line antibiotic treatment. A review of the literature published since 1996
has been performed, to provide a general overview on this topic.
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Background
Listeria (L.) monocytogenes is a gram-positive facultative
intracellular bacteria transmitted to humans through in-
gestion of contaminated food, in particular ready-to-eat
food, products with a long shelf life, deli meats and soft
cheeses. It typically affects pregnant women, neonates,
the elderly and immunocompromised patients [1]. An
infection during pregnancy can cause abortion, prema-
ture birth and amniositis, whereas in neonates it can
cause late-onset meningitis, conjunctivitis and pneumo-
nia. In immunocompromised patients Listeria causes
central nervous system infection, endocarditis, and sep-
sis [2]. There are rare reports of Listeria meningitis in
previously healthy and immunocompetent children,
which may be associated with severe complications and
a high mortality rate [2].
The clinical symptoms of Listeria meningitis are simi-
lar to those of other causes of meningoencephalitis and
first-line treatment with third-generation cephalosporins
is ineffective. Awareness of this pathogen is therefore
crucial, to enable adequate treatment to be started and
the best outcome to be achieved.
We report on a case of Listeria meningitis in a previ-
ously healthy 16-month-old girl. We also review litera-
ture reports of this condition in post-neonatal
immunocompetent children, published in English since
1996, in order to discuss its clinical presentation, diag-
nosis, treatment options and prognosis.
Case presentation
A previously healthy, fully immunized, 16-month-old girl
was hospitalized for high grade fever (maximum axillary
temperature of 39.8 °C), vomiting and refusal to feed of 4
days’ duration and irritability of recent onset. She had been
receiving oral antibiotic treatment with amoxicillin-
clavulanic acid (50mg/kg/day every 8 h) for 24 h, without
any clinical improvement. On admission (day 1) the patient
was irritable but in good general condition. Physical find-
ings were as follows: body weight 11 kg; heart rate 101
beats/min; body temperature 38 °C; oxygen saturation in
room air 98%; blood pressure 90/50mmHg. The cardiore-
spiratory and abdominal examinations were normal and no
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skin rash was observed. There was no sign of meningitis.
Laboratory tests showed elevated white blood cell (WBC)
counts of 14,090/mmc (75.7% neutrophils), while the
C-reactive protein (CRP) concentration was 5.76mg/dl
(normal value < 0.5mg/dl). Electrolytes, renal function and
coagulation tests were within the normal range. Given her
vomiting, the ongoing oral antibiotic treatment was stopped
and intravenous ceftriaxone (100mg/kg/day in a single
dose) was started in the suspicion of a bacterial infection.
On day 2 the patient rapidly worsened. She was lethar-
gic and preferred the lying position. Neck stiffness and
Brudzinski’s sign were also noted. A computed tomog-
raphy scan of the brain was normal, with no signs of in-
creased intracranial pressure. A lumbar puncture was
performed, revealing clear cerebrospinal fluid (CSF) con-
taining 840 cells/mmc with neutrophilic predominance
and glucose and protein concentrations of 38 and 44mg/
dl respectively. Empiric parenteral antibiotic treatment
with ceftriaxone (100mg/kg/day) was continued and
intravenous antiviral therapy with acyclovir (30mg/kg/day
in 3 doses) was started. Gram-staining resulted negative.
On day 3, a real-time polymerase chain reaction
(RT-PCR) for viruses and bacteria was positive for L.
monocytogenes. Ceftriaxone was therefore discontinued
and intravenous ampicillin (200 mg/kg/day in 4 doses)
and gentamicin (5 mg/kg/day) were started.
On day 4, the CSF culture identified L. monocytogenes,
while the blood culture was negative. A brain magnetic
resonance imaging scan showed mild meningeal enhance-
ment without any sign of parenchymal involvement.
The patient improved rapidly after the initiation of
ampicillin and gentamicin. She was completely afebrile
from day 7 and was progressively alert and communica-
tive by day 10. Ampicillin and gentamicin were contin-
ued for a total of 21 days, while acyclovir was continued
until the RT-PCR for Herpes simplex viruses proved
negative. The patient was discharged after 22 days in
good general condition and without any neurologic se-
quelae. Immunological screening, including an evalu-
ation of cellular immunity (total and subpopulations of
T cells), humoral immunity (immunoglobulin levels and
subclass IgG) and complement (C3, C4, AP50, CH50),
was normal. An HIV test was negative and there was no
iron overload. A hearing test (auditory evoked poten-
tials) was normal. At a follow-up visit after 1 month, her
clinical presentation was normal and there were no signs
of the disease. No source of infection was clarified in her
recent history.
Discussion and conclusion
L. monocytogenes meningoencephalitis in previously
healthy immunocompetent children is rare, but it can
progress rapidly and may be associated with severe com-
plications, such as acute hydrocephalus, and a high
mortality rate [3]. Early diagnosis and adequate treat-
ment are therefore essential to achieve the best outcome.
Unfortunately, adequate therapy might be delayed, and it
is essential that Listeria meningitis is considered in cases
that do not improve following first-line treatment with
extended-spectrum cephalosporins for central nervous
system infections.
To discuss the clinical presentation, diagnosis, treatment
and prognosis of this disease, we performed a literature re-
view of Listeria meningitis in previously healthy children
without any immunological disorders, in order to help pe-
diatricians promptly recognize and treat it. We identified
16 case reports involving 21 patients with Listeria menin-
gitis published in English since 1996. Most of these cases
shows similarities with our own case report.
The clinical presentation of Listeria meningitis is
non-specific and similar to that seen with other types of
viral or bacterial meningitis. The signs and symptoms in-
clude fever, headache, vomiting, diarrhea and altered
mental status [1–16], as also seen in our case. Abducens
nerve palsy and nystagmus have also been reported
among the initial signs of clinical presentation in some
cases [8, 10, 12, 13]. Listeria meningitis was preceded by
rotavirus gastroenteritis and by meningococcal B menin-
gitis in two cases [13, 14]. The age at presentation varied
from 7months to 10 years. Most children, including our
patient, presented with leukocytosis with neutrophilia
and with elevated CRP. Lumbar puncture is essential for
diagnosis, as blood cultures are often negative: only 5
cases had a blood culture positive for L. monocytogenes
[2, 3, 5, 8, 12]. CSF analysis reveals in most cases pleocy-
tosis with neutrophilia, reduced glucose concentration
and increased protein levels.
Gram-staining is of limited use as it is negative in
most cases. However, positivity for bacillus bacteria
should not be automatically considered as a contamin-
ant. In our case, gram-staining was negative, but
RT-PCR was rapidly positive for L. monocytogenes, con-
firming the utility of this technique in identifying this
pathogen and in guiding adequate antibiotic therapy [17,
18]. Initial CSF gram-staining and culture were reported
as negative in a few cases at the first lumbar puncture
[2, 3, 6]. Repetition of the CSF analysis is therefore ad-
vised in cases of severe meningoencephalitis that do not
improve with first-line antibiotic treatment where no
specific organism was identified on initial evaluation [2].
Finally, in one case diagnosis was based on serologic
tests [9]. However, serologic testing for Listeria meningi-
tis lacks specificity and should only be used for retro-
spective diagnosis [15].
First-line empiric treatment of meningitis frequently in-
cludes third-generation cephalosporins and vancomycin
to target the most common pathogens [19]. However,
once L. monocytogenes has been isolated from the CSF, the
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treatment should be adjusted to include ampicillin alone
or in combination with an aminoglycoside, such as genta-
micin or amikacin. Only one in-vitro study has demon-
strated that this association is synergic [20]. Although
vancomycin may be effective against L. monocytogenes on
in-vitro testing, it has had a high failure rate clinically [2].
Furthermore, its penetration in CSF is poor [21].
Trimethoprim-sulfamethoxazole was recently de-
scribed as an effective alternative in CNS listeriosis re-
fractory to conventional treatment [12]. Carbapenems,
used alone or in combination with aminoglycoside, have
also produced good results [3, 5, 6]. The treatment dur-
ation varied from 10 days to a maximum of 8 weeks, de-
pending on the severity of the case. In our case, 21 days
of ampicillin and gentamicin were sufficient and the pa-
tient was discharged without any sequelae. Table 1 sum-
marizes the main characteristics of Listeria meningitis in
healthy and immunocompetent children.
As L. monocytogenes mainly affects immunocomprom-
ised hosts, an immunological evaluation could be useful.
Underlying causes of immunosuppression, such as pro-
longed or inappropriate corticosteroid treatment, should
be excluded [9]. Finally, blood iron levels should be
checked, as iron overload could predispose to Listeria
meningitis [22].
L. monocytogenes is a rare cause of meningoencephal-
itis in previously healthy, immunocompetent children.
However, its clinical presentation is similar to that of
other viral or bacterial CNS infections and its course
can be rapid and aggressive. Physicians should therefore
always consider L. monocytogenes as a possible etiologic
agent of meningoencephalitis, especially in cases that are
unresponsive to the empiric first-line antibiotic treat-
ment and when gram-positive bacilli are observed in the
CSF. Furthermore, real-time PCR, as in our case, may be
useful for prompt diagnosis, which is essential to enable
adequate antibiotic treatment to be started with ampicil-
lin alone or in combination with aminoglycoside.
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